Azafaros concludes Phase III trial recruitment for GM1/GM2 gangliosidoses – Clinical Trials Arena July 24, 2026 by Sarkari Results Azafaros concludes Phase III trial recruitment for GM1/GM2 gangliosidoses Clinical Trials Arena